Why Credit Corp, GUD, Race Oncology, and Spartan Resources shares are rising

These shares are having a decent session. But why?

| More on:
A man sees some good news on his phone and gives a little cheer.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The S&P/ASX 200 Index (ASX: XJO) is having a tough session on Tuesday. In afternoon trade, the benchmark index is down 0.4% to 7,719.1 points.

Four ASX shares that are not letting that hold them back today are listed below. Here's why they are rising:

Credit Corp Group Limited (ASX: CCP)

The Credit Corp share price is up almost 4% to $15.44. Investors have been buying this debt collector's shares on Tuesday after they were the subject of a bullish broker note out of Macquarie. According to the note, the broker has upgraded Credit Corp's shares to an outperform rating with an $18.32 price target. Macquarie highlights that the company's shares are trading at a deep discount to long term multiples. It feels this make now an opportune time for investors to initiate an investment. And judging by its gain today, it seems that the investors agree.

GUD Holdings Limited (ASX: GUD)

The GUD Holdings share price is up 11.5% to $10.90. This has been driven by the release of a trading update from the auto parts company. Management revealed that it remains on course to achieve its guidance in FY 2024. This will mean underlying earnings before interest, taxes and amortisation (EBITA) of at least $193.5 million. That's despite its AutoPacific Group (APG) segment performing a touch below expectations. Management revealed that this reflects the ongoing execution of its diversification strategy and the resilience of the aftermarket parts market.

Race Oncology Ltd (ASX: RAC)

The Race Oncology share price is up 8% to $1.67. This follows the release of results from recent preclinical work performed under contract at Oncolines in the Netherlands. The release notes that in these studies, its bisantrene product was screened in combination with decitabine for enhanced anticancer activity across a broad panel of 143 cancer cell lines. Race CEO, Dr Daniel Tillett, commented: "These results open exciting new treatment opportunities for both bisantrene and decitabine."

Spartan Resources Ltd (ASX: SPR)

The Spartan Resources share price is up 3% to 65.3 cents. This morning, this gold developer revealed that it has completed the retail component of its fully underwritten pro rata accelerated non-renounceable entitlement offer. The retail entitlement offer raised a total of approximately $11 million at the offer price of 58 cents per new share. This brings the total raised to approximately $80 million. Proceeds will be used to underpin a significantly expanded exploration campaign at the Dalgaranga Gold Project.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Macquarie Group. The Motley Fool Australia has positions in and has recommended Macquarie Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

three businessmen high five each other outside an office building with graphic images of graphs and metrics superimposed on the shot.
Share Gainers

Why Brazilian Rare Earths, COG, Develop Global, and Guzman Y Gomez shares are storming higher

These shares are having a strong session on Thursday. Let's find out why.

Read more »

Three rockets heading to space
Share Gainers

Guess which ASX All Ords mining stock is rocketing 36% on big news

Investors are piling into the ASX All Ords miner today. But why?

Read more »

A man clenches his fists in excitement as gold coins fall from the sky.
Share Gainers

Why DroneShield, James Hardie, Lifestyle Communities, and Mesoblast shares are storming higher

These shares are having a good time on hump day. But why?

Read more »

A smiling businessman in the city looks at his phone and punches the air in celebration of good news.
Share Gainers

Why DroneShield, Novonix, Predictive Discovery, and Weebit Nano shares are charging higher

These shares are starting the week on a high. But why?

Read more »

Ecstatic man giving a fist pump in an office hallway.
Share Gainers

Why did DroneShield shares rocket 41% in September?

Let's see why this popular stock delivered very big returns last month.

Read more »

These three ASX mining shares rocketed by more than 20% today
Share Gainers

3 ASX 200 stocks rocketing higher this week

These three ASX 200 stocks are up 15%, 26%, and 50% this week!

Read more »

A group of four business people sit around a desk and laptops clapping and smiling.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a happy Thursday session for the markets today.

Read more »

A man clenches his fists in excitement as gold coins fall from the sky.
Share Gainers

Why Bravura, Dateline, Orthocell, and Race Oncology shares are storming higher

These shares are having a strong session on Thursday. But why?

Read more »